JPS624042B2 - - Google Patents
Info
- Publication number
- JPS624042B2 JPS624042B2 JP54070464A JP7046479A JPS624042B2 JP S624042 B2 JPS624042 B2 JP S624042B2 JP 54070464 A JP54070464 A JP 54070464A JP 7046479 A JP7046479 A JP 7046479A JP S624042 B2 JPS624042 B2 JP S624042B2
- Authority
- JP
- Japan
- Prior art keywords
- chitin
- formula
- degree
- deacetylated
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229920002101 Chitin Polymers 0.000 claims description 33
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 22
- 150000003839 salts Chemical class 0.000 claims description 12
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims description 8
- 229960000633 dextran sulfate Drugs 0.000 claims description 8
- 229960002897 heparin Drugs 0.000 claims description 8
- 229940059329 chondroitin sulfate Drugs 0.000 claims description 7
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims description 6
- 229920001287 Chondroitin sulfate Polymers 0.000 claims description 6
- 230000006196 deacetylation Effects 0.000 claims description 6
- 238000003381 deacetylation reaction Methods 0.000 claims description 6
- 229920000831 ionic polymer Polymers 0.000 claims description 6
- 229920002971 Heparan sulfate Polymers 0.000 claims description 5
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims description 5
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims description 5
- 229950006780 n-acetylglucosamine Drugs 0.000 claims description 5
- 229910052783 alkali metal Inorganic materials 0.000 claims description 2
- 150000001340 alkali metals Chemical group 0.000 claims description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 2
- 150000001342 alkaline earth metals Chemical group 0.000 claims description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-O ammonium group Chemical group [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000001257 hydrogen Substances 0.000 claims description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 description 14
- 239000000047 product Substances 0.000 description 14
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- 239000003125 aqueous solvent Substances 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 230000002785 anti-thrombosis Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229920000669 heparin Polymers 0.000 description 4
- 239000005518 polymer electrolyte Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 229920001661 Chitosan Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920003045 dextran sodium sulfate Polymers 0.000 description 2
- 238000000502 dialysis Methods 0.000 description 2
- JXTHNDFMNIQAHM-UHFFFAOYSA-N dichloroacetic acid Chemical compound OC(=O)C(Cl)Cl JXTHNDFMNIQAHM-UHFFFAOYSA-N 0.000 description 2
- 238000002329 infrared spectrum Methods 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000029936 alkylation Effects 0.000 description 1
- 238000005804 alkylation reaction Methods 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229960002086 dextran Drugs 0.000 description 1
- 229960005215 dichloroacetic acid Drugs 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- ZFGMDIBRIDKWMY-PASTXAENSA-N heparin Chemical compound CC(O)=N[C@@H]1[C@@H](O)[C@H](O)[C@@H](COS(O)(=O)=O)O[C@@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O[C@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@@H](O[C@@H]3[C@@H](OC(O)[C@H](OS(O)(=O)=O)[C@H]3O)C(O)=O)O[C@@H]2O)CS(O)(=O)=O)[C@H](O)[C@H]1O ZFGMDIBRIDKWMY-PASTXAENSA-N 0.000 description 1
- 229960001008 heparin sodium Drugs 0.000 description 1
- 150000002431 hydrogen Chemical group 0.000 description 1
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 125000003010 ionic group Chemical group 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000867 polyelectrolyte Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Description
本発明は、デキストラン硫酸エステル,ヘパリ
ン,コンドロイチン硫酸のいずれかと、カルボキ
シメチルキチン又はその塩の脱アセチル化物とか
ら成る、抗血栓性にすぐれるポリイオンコンプレ
ツクス(以下PCと略称する)及び該ポリイオン
コンプレツクスの製造法に係る。
PCは、正の電荷をもつ高分子電解質と負の電
荷をもつ高分子電解質とを溶媒中で反応せしめる
ことによつて得られる複合体である。
このPC反応は、生体における多糖類と蛋白質
との相互作用に代表される如く、生体系の反応モ
デルとして大変興味深いものである。
近年、このPC反応を利用して得られる材料
は、医療或いは生体への機能性材料として、例え
ば透析膜,限外過材として注目されつつある。
PC材を生体材料として使用する場合、PCの構
成成分或いはそれ自身が、生体に対して親和性で
あること、毒性のないこと及び安定であることが
不可欠である。この点、キチンは化学的,生体的
に安定且つ安全であり、キチン質を主体とした
PCが開発されれば画期的なものとなる。
しかし乍ら、キチンは極めて高結晶性で且つそ
のアミノアセチル基の結合が強固であるため、セ
ルロースにおける如く、良好に溶解,分散或いは
膨潤させる溶剤がない。即ち、キチンの溶剤とし
て例えばジクロル酢酸,硫酸,ギ酸等があるが、
これらの溶剤は、キチンの分子量低下や分解を伴
う溶剤であり、また廃液処理等の取扱い上の問題
を多々有するものである。このため、キチンの溶
剤可溶化のために、例えばアルキル化或いはアセ
チル化処理して可溶性キチン誘導体の合成が試み
られている。
しかし乍ら、従来、溶剤に可溶なものとしてキ
チンの脱アセチル化物であるキトサン及びその誘
導体が提案されているにすぎず、キチン系PCと
してキトサン硫酸化ポリビニールアルコールとの
PC(特開昭50−8879号公報)及びキトサンと硫
酸化セルロースとのPC(特開昭50−123179号公
報)が提供されている。
本発明者らは、キチンの利用開発につき鋭意研
究を進める過程において、キチン誘導体の中でカ
ルボキシメチルキチンまたはその塩の脱アセチル
化物が酸或いはアルカリ水溶液に可溶であり、し
かも脱アセチル化物はカルボキシル基とアミノ基
を併有する両性高分子電解質であり、これとデキ
ストラン硫酸エステル,ヘパリン,或いはコンド
ロイチン硫酸のいずれかと反応せしめて得られる
PCは、生体適合性或いは生体安定性にすぐれる
とともに抗血栓性に秀いでていることを知見し、
本発明に到達したものである。
即ち、本発明は、両イオン性であるカルボキシ
メチルキチンまたはその塩の脱アセチル化物にデ
キストラン硫酸エステル,ヘパリン或いはコンド
ロイチン硫酸のいずれかを反応せしめてなる抗血
栓性にすぐれる新規PC及びその製造法を提供す
るものである。
本発明で用いるカルボキシメチルキチンの脱ア
セチル化物は、例えば以下の手順によつて入手出
来る。
即ち、カニ,エビ等の節足動物の甲殻等から常
法によつて分離精製して得られる一般式()で
示されるキチンを、モノクロル酢酸等と反応させ
ることによりカルボキシメチル化し、一般式
()で示される構造単位を含むカルボキシメチ
ルキチンまたはその塩を得る。
The present invention relates to a polyion complex (hereinafter abbreviated as PC) with excellent antithrombotic properties, which is composed of dextran sulfate, heparin, chondroitin sulfate, and a deacetylated product of carboxymethyl chitin or a salt thereof, and the polyion complex. Concerning the manufacturing method of Tsukusu. PC is a complex obtained by reacting a positively charged polymer electrolyte and a negatively charged polymer electrolyte in a solvent. This PC reaction is very interesting as a reaction model for biological systems, as typified by the interaction between polysaccharides and proteins in living organisms. In recent years, materials obtained using this PC reaction have been attracting attention as functional materials for medical treatment or living organisms, such as dialysis membranes and ultrafiltration materials. When using a PC material as a biomaterial, it is essential that the constituent components of the PC or itself are compatible with the living body, non-toxic, and stable. In this respect, chitin is chemically and biologically stable and safe, and
If a PC were developed, it would be revolutionary. However, since chitin is extremely highly crystalline and has strong aminoacetyl group bonds, there is no solvent that can dissolve, disperse, or swell it as well as cellulose. That is, examples of solvents for chitin include dichloroacetic acid, sulfuric acid, and formic acid.
These solvents are associated with a decrease in the molecular weight and decomposition of chitin, and also have many problems in handling such as waste liquid treatment. Therefore, in order to solubilize chitin in a solvent, attempts have been made to synthesize soluble chitin derivatives by, for example, alkylation or acetylation treatment. However, so far only chitosan, which is a deacetylated product of chitin, and its derivatives have been proposed as solvent-soluble substances, and chitosan and sulfated polyvinyl alcohol have been proposed as chitin-based PC.
PC (JP-A-50-8879) and PC of chitosan and sulfated cellulose (JP-A-50-123179) have been provided. In the process of intensive research into the development of the use of chitin, the present inventors discovered that among chitin derivatives, deacetylated products of carboxymethyl chitin or its salts are soluble in acid or alkaline aqueous solutions, and that the deacetylated products are carboxymethyl chitin. It is an amphoteric polymer electrolyte that has both groups and amino groups, and can be obtained by reacting it with either dextran sulfate, heparin, or chondroitin sulfate.
It was discovered that PC has excellent biocompatibility and biostability as well as excellent antithrombotic properties,
This has led to the present invention. That is, the present invention provides a novel PC with excellent antithrombotic properties, which is obtained by reacting a deacetylated product of carboxymethyl chitin or its salt, which is amphoteric, with dextran sulfate, heparin, or chondroitin sulfate, and a method for producing the same. It provides: The deacetylated carboxymethyl chitin used in the present invention can be obtained, for example, by the following procedure. That is, chitin represented by the general formula () obtained by separating and purifying the shells of arthropods such as crabs and shrimps by conventional methods is carboxymethylated by reacting with monochloroacetic acid, etc., to obtain the general formula ( ) to obtain carboxymethyl chitin or a salt thereof containing the structural unit.
【式】【formula】
【式】或いは[Formula] or
【式】
(式中、Mは水素,アルカリ金属,アルカリ土
類金属,アンモニウム基を示す。)
本発明におけるカルボキシメチルキチンまたは
その塩は単位構造であるN−アセチル−D−グル
コサミン当りのカルボキシメチル基が0.1〜1.0好
ましくは0.3〜1.0である。
次いで、該カルボキシメチルキチンまたはその
塩を水酸化ナトリウム,水酸化カリウム等のアル
カリ水溶液中で加熱して脱N−アセチル化し、本
発明の水系溶媒に可溶の両性高分子電解質、即
ち、カルボキシメチルキチンまたはその塩の脱ア
セチル化物を得ることができる。
本発明の前記脱アセチル化物の脱アセチル化度
は、0.1〜1.0好ましくは0.3〜1.0である。カルボ
キシメチルキチンの脱アセチル化物の製造例が特
願昭56−161391に開示されている。本発明は、特
願昭53−161391の開示内容をも包含する。
本発明のカルボキシメチルキチンの脱アセチル
化物のカチオン性を示す典型的構成単位を例示す
ると次のとおりである(式を概略的に示す)。[Formula] (In the formula, M represents hydrogen, an alkali metal, an alkaline earth metal, or an ammonium group.) Carboxymethyl chitin or a salt thereof in the present invention is carboxymethyl per unit structure N-acetyl-D-glucosamine. The group is 0.1 to 1.0, preferably 0.3 to 1.0. Next, the carboxymethyl chitin or its salt is heated in an alkaline aqueous solution such as sodium hydroxide or potassium hydroxide to de-N-acetylate it, and the amphoteric polyelectrolyte soluble in the aqueous solvent of the present invention, that is, carboxymethyl A deacetylated product of chitin or its salt can be obtained. The degree of deacetylation of the deacetylated product of the present invention is 0.1 to 1.0, preferably 0.3 to 1.0. An example of producing a deacetylated product of carboxymethyl chitin is disclosed in Japanese Patent Application No. 161391/1983. The present invention also includes the contents disclosed in Japanese Patent Application No. 53-161391. Examples of typical structural units exhibiting cationic properties of the deacetylated carboxymethyl chitin of the present invention are as follows (the formulas are schematically shown).
【式】【formula】
【式】【formula】
【式】
本発明PC形成のための他方の反応物であるデ
キストラン硫酸エステル,ヘパリン,コンドロイ
チン硫酸は市販のものでも良い。
本発明のイオン性高分子電解質は、いずれも水
系溶媒に可溶であるため、特に有機溶媒を用いる
ことなく、容易にPCを製造することができる。
即ち、本発明のPCは、前記カルボキシメチルキ
チンまたはその塩の脱アセチル化物を水系溶媒に
溶解せしめ、これに反応せしめるデキストラン硫
酸エステル,ヘパリン又はコンドロイチン硫酸を
溶解した溶液を混合撹拌し、生成するPCを過
分離,水洗を行うことにより得ることができる。
用いる水系溶媒は、酸或いはアルカリの水溶液で
あり、該水溶液濃度は、溶液粘度との関係から任
意なもので良く、通常0.5〜5%程度である。な
お、該溶液粘度が高い場合は、不均一なPC或い
はゲル状となり易いので注意が必要である。
また、該製造における反応温度は、水系溶媒使
用のため、100℃以下でよいが、好ましくは5〜
40℃である。
PC形成の確認は元素分析,赤外分光分析及び
溶解性試験によつて行うことが出来る。このよう
にして得られる本発明のPCは、ウベローデ型粘
度計で20℃での極限粘度〔ηsp/c〕0.1〜20の
範囲にある。
本発明のPCは、その構造を化学式で明確に示
すことは困難であるが、カルボキシメチルキチン
の脱アセチル化物の−NH3とヘパリン,コンド
ロイチン又はデキストラン硫酸エステルの−
SO3又は−COOとの間で主として静電気に結
合して成るイオン橋かけ網状構造であると考えら
れる。本発明によつて得られるPCは、カルボキ
シメチルキチンまたはその塩の脱アセチル化物の
相手側が溶解する水素イオン濃度(PH)の水溶
液に可溶であると共に、中性塩の水溶液でも可溶
であり、極めて加工性にすぐれるものである。
従つて、本発明のPCを該水溶液に溶解し、フ
イルム或いは繊維状とした後、脱塩処理すること
により、容易に不溶性とすることができる。
また、不溶化は、熱処理,紫外線処理,架橋剤
処理によつて行うことができる。
このようにして得られる本発明のPC成形体
は、耐薬品性,耐熱性にすぐれると共に、天然キ
チン由来のものであるので生体内で安定であり、
抗血栓性を有し且つイオン性基を有するのでマイ
クロカプセル材,透析膜或いは限外過膜,人工
臓器,手術用材料、そのほか湿気を呼吸する材料
として利用出来る。
以下実施例をもつて本発明を詳述する。
実施例 1
市販のデキストラン硫酸ナトリウム(分子量50
万、半井化学製、S含有率18.8%)38gを水1
に溶解する。
次にカルボキシメチルキチンの脱アセチル化物
のナトリウム塩(カルボキシメチル化度0.5、脱
アセチル化度1.0、極限粘度8.5)23gを水2に
溶解し、撹拌しながら前記デキストラン硫酸ナト
リウム水溶液をゆつくり加えていくと白濁し、更
に沈澱を生ずる。
この沈澱を過し、水洗し、更にエタノールで
洗いを乾燥すると白色の固体が得られ、収量は51
gでほぼ100%に近かつた。
IRスペクトルから1510cm-1に−NH3,1210,
1040cm-1に−SO3の吸収がみられ、元素分析値
においてS含有率は12.0%でほぼ1:1のポリイ
オンコンプレツクスを形成している事がみとめら
れた。
この物質の極限粘度は、0.1Nカセイソーダ水
溶液中20℃で14.5であつた。
実施例 2
実施例1のカルボキシメチルキチンの脱アセチ
ル化物46gを増して水2に溶解し、デキストラ
ン硫酸を実施例1と同量とし、以下実施例1と同
様の操作を行なつた。収量は69gでほぼ100%に
近かつた。
IRスペクトルから1510cm-1に−NH3,1210,
1040cm-1に−SO3の吸収がみられ、実施例1よ
りもより吸収が大きくなつている。元素分析値に
おいてS含有率は9.0%でほぼ1:2(デキスト
ラン/脱アセチル化物)の組成のPCが得られ
た。この物質の極限粘度は、0.1Nカセイソーダ
水溶液中20℃で13.2であつた。
実施例 3
カルボキシメチルキチンの脱アセチル化物のナ
トリウム塩(カルボキシメチル化度0.3、脱アセ
チル化度0.5、極限粘度9.0)10gを水500c.c.に溶
解し、ガラス板に流し込み、40℃で乾燥する。こ
れを1%ヘパリン,ナトリウム水溶液(ノボ製)
200c.c.中に37℃で浸漬するとフイルムの表面が白
濁し、不溶化する。
この不透明なフイルムを水洗し、乾燥すると透
明なフイルムが得られ、次の様な物性を示した。[Formula] Dextran sulfate, heparin, and chondroitin sulfate, which are the other reactants for forming PC of the present invention, may be commercially available. Since all of the ionic polymer electrolytes of the present invention are soluble in aqueous solvents, PC can be easily produced without particularly using an organic solvent.
That is, the PC of the present invention is a PC produced by dissolving the deacetylated product of carboxymethyl chitin or a salt thereof in an aqueous solvent, and mixing and stirring a solution in which dextran sulfate, heparin, or chondroitin sulfate to be reacted with this is dissolved. can be obtained by over-separation and washing with water.
The aqueous solvent used is an acid or alkali aqueous solution, and the concentration of the aqueous solution may be arbitrary in view of the relationship with the viscosity of the solution, and is usually about 0.5 to 5%. Note that when the viscosity of the solution is high, care must be taken because it tends to become non-uniform PC or gel-like. In addition, the reaction temperature in this production may be 100°C or less because an aqueous solvent is used, but preferably 5 to 100°C.
It is 40℃. Confirmation of PC formation can be performed by elemental analysis, infrared spectroscopy and solubility testing. The PC of the present invention thus obtained has an intrinsic viscosity [η sp/c] of 0.1 to 20 at 20° C. as measured by an Ubbelohde viscometer. Although it is difficult to clearly express the structure of the PC of the present invention with a chemical formula, it is possible to combine -NH3, a deacetylated product of carboxymethyl chitin, and -NH3 , which is a deacetylated product of carboxymethyl chitin, and a -NH3 product of heparin, chondroitin, or dextran sulfate.
It is thought to be an ion-bridged network structure mainly formed by electrostatic bonds with SO 3 or -COO. The PC obtained by the present invention is soluble in an aqueous solution with a hydrogen ion concentration (PH) that dissolves the other side of the deacetylated product of carboxymethyl chitin or its salt, and is also soluble in an aqueous solution of a neutral salt. , it has extremely good workability. Therefore, the PC of the present invention can be easily made insoluble by dissolving it in the aqueous solution, making it into a film or fiber, and then desalting it. Moreover, insolubilization can be performed by heat treatment, ultraviolet treatment, and crosslinking agent treatment. The thus obtained PC molded article of the present invention has excellent chemical resistance and heat resistance, and is stable in vivo because it is derived from natural chitin.
Since it has antithrombotic properties and ionic groups, it can be used as microcapsule materials, dialysis membranes or ultrafiltration membranes, artificial organs, surgical materials, and other moisture-breathing materials. The present invention will be described in detail below with reference to Examples. Example 1 Commercially available dextran sodium sulfate (molecular weight 50
Manufactured by Hanui Chemical, S content 18.8%) 38g with water 1
dissolve in Next, 23 g of sodium salt of deacetylated carboxymethyl chitin (degree of carboxymethylation 0.5, degree of deacetylation 1.0, intrinsic viscosity 8.5) was dissolved in 2 parts of water, and the above aqueous solution of dextran sodium sulfate was slowly added while stirring. As it goes on, it becomes cloudy and further precipitates form. This precipitate was filtered, washed with water, further washed with ethanol, and dried to obtain a white solid, with a yield of 51
g was close to 100%. From the IR spectrum at 1510 cm -1 −NH 3 , 1210,
Absorption of -SO 3 was observed at 1040 cm -1 , and elemental analysis revealed that the S content was 12.0%, forming a polyion complex of approximately 1:1. The intrinsic viscosity of this material was 14.5 at 20°C in a 0.1N aqueous solution of caustic soda. Example 2 46 g of the deacetylated carboxymethyl chitin from Example 1 was increased and dissolved in 2 waters, and the same amount of dextran sulfate as in Example 1 was used, and the same operations as in Example 1 were carried out. The yield was 69g, which was close to 100%. From the IR spectrum at 1510 cm -1 −NH 3 , 1210,
Absorption of -SO 3 is observed at 1040 cm -1 , and the absorption is larger than in Example 1. According to elemental analysis, the S content was 9.0%, and a PC with a composition of approximately 1:2 (dextran/deacetylated product) was obtained. The intrinsic viscosity of this material was 13.2 at 20°C in a 0.1N aqueous solution of caustic soda. Example 3 10 g of sodium salt of deacetylated carboxymethyl chitin (degree of carboxymethylation 0.3, degree of deacetylation 0.5, intrinsic viscosity 9.0) was dissolved in 500 c.c. of water, poured into a glass plate, and dried at 40°C. do. Add this to 1% heparin, sodium aqueous solution (manufactured by Novo)
When immersed in 200c.c. at 37℃, the surface of the film becomes cloudy and insolubilized. When this opaque film was washed with water and dried, a transparent film was obtained, which exhibited the following physical properties.
【表】
実施例 4
実施例1の得られたPC10gを、5%アンモニ
ア水溶液200c.c.に溶解し、それをガラス板に流し
込み、40℃でアンモニア及び水を除すると透明な
フイルムが得られた。
実施例 5
カルボキシメチルキチンの脱アセチル化物のナ
トリウム塩(カルボキシメチル化度0.3、脱アセ
チル化度0.5)10gを水500c.c.に溶解し、5℃で1
%グルタルアルデヒド水溶液100c.c.と5分間反応
させた後、ガラス板に流し込み40℃で乾燥する。
得られたフイルムを1%ヘパリンナトリウム水
溶液100c.c.に室温で浸漬するとフイルムの表面が
白濁し、ポリイオンコンプレツクスを形成する。
この白く濁つた不透明なフイルムを水洗し、乾燥
すると透明なフイルムが得られる。[Table] Example 4 10 g of PC obtained in Example 1 was dissolved in 200 c.c. of 5% ammonia aqueous solution, poured into a glass plate, and ammonia and water were removed at 40°C to obtain a transparent film. Ta. Example 5 10 g of sodium salt of deacetylated carboxymethyl chitin (degree of carboxymethylation 0.3, degree of deacetylation 0.5) was dissolved in 500 c.c. of water, and 1
% glutaraldehyde aqueous solution for 5 minutes, poured onto a glass plate and dried at 40°C. When the obtained film is immersed in 100 c.c. of 1% heparin sodium aqueous solution at room temperature, the surface of the film becomes cloudy and a polyion complex is formed.
When this white, cloudy, opaque film is washed with water and dried, a transparent film is obtained.
Claims (1)
ドロイチン硫酸とからなる群から選ばれる少なく
とも1種と、構造単位N−アセチル−D−グルコ
サミン当り0.1乃至1.0のカルボキシメチル化度を
有し、且つ、構造単位N−アセチル−D−グルコ
サミン当り0.1乃至1.0の脱アセチル化度を有する
カルボキシメチルキチンもしくはその塩の脱アセ
チル化物とからなる、20℃で0.1乃至20の極限粘
度を有するポリイオンコンプレツクス。 2 前記脱アセチル化物が、構造単位N−アセチ
ル−D−グルコサミン当り0.3乃至1.0のカルボキ
シメチル化度を有する下記式で表わされるカルボ
キシメチルキチンもしくはその塩の、
【式】又は 【式】 (式中、Mは水素,アルカリ金属,アルカリ土
類金属又はアンモニウム基を示す) 構造単位N−アセチル−D−グルコサミン当り
0.3乃至1.0の脱アセチル化度を有する脱アセチル
化物であることを特徴とする特許請求の範囲第1
項に記載のポリイオンコンプレツクス。[Scope of Claims] 1. At least one member selected from the group consisting of dextran sulfate, heparin, and chondroitin sulfate, and a degree of carboxymethylation of 0.1 to 1.0 per structural unit N-acetyl-D-glucosamine, and , a deacetylated product of carboxymethyl chitin or a salt thereof having a degree of deacetylation of 0.1 to 1.0 per structural unit N-acetyl-D-glucosamine, and having an intrinsic viscosity of 0.1 to 20 at 20°C. 2. Carboxymethyl chitin or a salt thereof represented by the following formula, in which the deacetylated product has a degree of carboxymethylation of 0.3 to 1.0 per structural unit N-acetyl-D-glucosamine,
[Formula] or [Formula] (In the formula, M represents hydrogen, alkali metal, alkaline earth metal, or ammonium group) Per structural unit N-acetyl-D-glucosamine
Claim 1, characterized in that it is a deacetylated product having a degree of deacetylation of 0.3 to 1.0.
Polyionic complexes as described in Section.
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7046479A JPS55161803A (en) | 1979-06-05 | 1979-06-05 | Polyion complex composed of chitin derivative |
US06/153,906 US4301067A (en) | 1979-06-05 | 1980-05-28 | Chitin containing poly-ion complex |
CA000353166A CA1158235A (en) | 1979-06-05 | 1980-06-02 | Chitin containing poly-ion complex |
DE8080301883T DE3064389D1 (en) | 1979-06-05 | 1980-06-05 | Poly-ion complex, process for its preparation and shaped articles prepared therefrom |
EP80301883A EP0020183B1 (en) | 1979-06-05 | 1980-06-05 | Poly-ion complex, process for its preparation and shaped articles prepared therefrom |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP7046479A JPS55161803A (en) | 1979-06-05 | 1979-06-05 | Polyion complex composed of chitin derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS55161803A JPS55161803A (en) | 1980-12-16 |
JPS624042B2 true JPS624042B2 (en) | 1987-01-28 |
Family
ID=13432259
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7046479A Granted JPS55161803A (en) | 1979-06-05 | 1979-06-05 | Polyion complex composed of chitin derivative |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS55161803A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH046146U (en) * | 1990-04-27 | 1992-01-21 |
-
1979
- 1979-06-05 JP JP7046479A patent/JPS55161803A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH046146U (en) * | 1990-04-27 | 1992-01-21 |
Also Published As
Publication number | Publication date |
---|---|
JPS55161803A (en) | 1980-12-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0020183B1 (en) | Poly-ion complex, process for its preparation and shaped articles prepared therefrom | |
Hudson et al. | Polysaccharides: chitin and chitosan: chemistry and technology of their use as structural materials | |
JP4230135B2 (en) | Method for producing glycosaminoglycan-collagen complex cross-linked by multifunctional cross-linking agent | |
EP0053473B1 (en) | Cellulose sulfate salt having anti-coagulating action and process for preparing same | |
KR20080071166A (en) | Cationized hyaluronic acid | |
JPH03502704A (en) | Method for producing water-insoluble biocompatible gel | |
CN107915848A (en) | A kind of preparation method of chitin whisker/hydroxyl butyl chitosan temperature-sensitive hydrogel | |
JP5340093B2 (en) | Method for producing crosslinked hyaluronic acid | |
JP4356289B2 (en) | Polysaccharide complex and method for producing the same | |
US4373096A (en) | Crosslinked chitin derivatives | |
US20030055211A1 (en) | Chitosan condensation products, their preparation and their uses | |
JPS60203265A (en) | Anti-blood coagulation polymer material | |
CN1297957A (en) | Preparation and use of intermingled film or fiber of carboxymethyl chitosan and alginic acid | |
Tokura et al. | Lysozyme-accessible fibers from chitin and its derivatives | |
JPS624042B2 (en) | ||
JPS624043B2 (en) | ||
JP5110046B2 (en) | Polysaccharide complex and method for producing the same | |
JPS6134004A (en) | Novel cationized chitin and its production | |
JPS624041B2 (en) | ||
JP2754162B2 (en) | Manufacturing method of chitin sponge, chitin paper and chitin film | |
JPH05239263A (en) | Water-containing gel composition | |
JPS624044B2 (en) | ||
Partain | Industrially important polysaccharides | |
JP2511675B2 (en) | Method for producing polyoxyethylenated chitin | |
US6025479A (en) | Method of preparing water swellable gel from chitin |